Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_assertion type Assertion NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_head.
- NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_assertion description "[Reduced or increased PNA binding was also observed in patients with increased (liver cirrhosis) or reduced (von Willebrand disease [VWD] type 1) VWF antigen levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_provenance.
- NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_assertion evidence source_evidence_literature NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_provenance.
- NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_assertion SIO_000772 17090649 NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_provenance.
- NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_assertion wasDerivedFrom befree-20140225 NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_provenance.
- NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_assertion wasGeneratedBy ECO_0000203 NP789040.RA8yBkxhdnCNdBsWNS36QP0ZEHA0VruSmhmddXALi8NTY130_provenance.